Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
April 17, 2019 at 03:10 pm
Share
Jiangxi Synergy Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was CNY 267.124 million compared to CNY 296.716 million a year ago. Operating income was CNY 26.281 million compared to CNY 72.760 million a year ago. Net income was CNY 24.530 million compared to CNY 65.457 million a year ago. Basic earnings per share from continuing operations was CNY 0.3049 compared to CNY 0.8688 a year ago. Diluted earnings per share from continuing operations was CNY 0.3016 compared to CNY 0.8634 a year ago.
Jiangxi Synergy Pharmaceutical Co Ltd is a pharmaceutical manufacturing company. The Company is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The Company's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The company's products are sold to domestic and foreign markets, including Europe, North America and Japan.
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. 
